データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
SciSparc Provides Updates on Status of Spin-off of Its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded Company
Sector Update: Consumer Stocks Edge Higher Pre-Bell Friday
SciSparc | 6-K:海外発行者報告書(決算情報)
Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome
SciSparc Receives FDA Approval To Launch Pivotal Phase IIb Trial For Tourette Syndrome Treatment SCI-110 In U.S., Following Promising Phase IIa Results Showing Up To 40% Tic Reduction
SciSparc: Amitay Weiss Also Serves as Chairman of Bd of Directors of Purchaser >SPRC
データなし